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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S62than did MIA-treated animals, whereas MIA-treated animals displayed
greater hindpaw allodynia than did MNX-treated animals.
Conclusions:We have compared two commonly induced models of OA in
rats, within a single experiment using identical assessment tools. Although
both models display features of OA, including chondropathy, osteopytosis,
synovitis and pain behaviour, differences between the models may indi-
cate that they each uniquely reﬂect different aspects of human OA. In
particular, the MNX model is characterised by greater synovitis and
osteophyte formation, and persistence of osteochondral channels, whereas
the MIA model is associated with more pronounced distal allodynia.
Appropriate selection of OA models depends on relevance to the research
hypothesis, and to OA phenotype which it is intended to model.
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DEVELOPMENT AND VALIDATION OF MECHANICAL ALLODYNIA AS
A PAIN READOUT IN A PRECLINICAL MODEL OF OSTEOARTHRITIS
R.V. Kamath 1, G. Simler 1, C. Zhou 2, M. Hart 1, S. Joshi 2, P. Honore 1. 1Abbott
Labs, Worcester, MA; 2Abbott Labs, Chicago, IL, USA
Purpose: Osteoarthritis (OA) is an age-related joint disease characterized
by progressive degeneration of articular cartilage and development of
chronic pain. Although a number of experimental models of OA have been
employed to investigate the underlying etiologies of cartilage degenera-
tion, there have been relatively few reports of the characterization of the
chronic pain associated with animal models of OA. Moreover, the appli-
cation of these models in the assessment of the analgesic efﬁcacy of
putative therapeutics remains largely unexplored. The purpose of the
present study was to develop and validate mechanical allodynia as a pain
readout with benchmark analgesics in the well-described and widely-used
destabilization of medial meniscus (DMM) model of OA.
Methods: Male sv129 mice were anesthetized and medial meniscotibial
ligament which anchors the medial meniscus to the tibial plateau was trans-
ected to induce OA. To determine optimal time-point for pain measurement,
decrease in paw withdrawal threshold (PWT) [mechanical allodynia (pain)]
was measured using von Frey ﬁlaments applied to the plantar surface of the
hind paw once every week after surgery for 5 weeks. To evaluate analgesics
efﬁcacy, on day 28 after surgery animals treated with either duloxetine; cel-
ecoxib or diclofenac were tested for PWT 60 minutes following oral adminis-
trationof thedrugwhile animals treatedwithgabapentinwere tested for PWT
180 minutes following oral administration of the drug.
Results: We have demonstrated that mice with DMM surgery were allo-
dynic as early as day 7 after surgery and exhibited a decrease in PWT
lasting through day 35. It was also observed that PWT in the sham group
was low indicating surgical pain during the early days following surgery
but PWT in sham animals recovered by Day 28 to normal values. Gaba-
pentin and duloxetine fully reversed established pain in a dose-related
manner while celecoxib and diclofenac partially reversed established pain
in a dose-related manner reaching a maximum inhibition of 62% and 64%
respectively at 30 mg/kg.
Conclusions: OA pain is a complex process involving both peripheral and
central sensitization. Development of analgesics drugs for OA has been
difﬁcult partly due to the lack of appropriate animal models to evaluate
pain in OA. We have reproduced and employed the mouse model of OA for
pain to evaluate the analgesic properties of benchmark analgesics. These
results suggest that this model could provide a tool to understand
molecular pathways involved in induction and maintenance of chronic
osteoarthritic pain and would also be useful in developing and evaluating
drugs for relieving OA pain.
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BLOCKADE OF BOTH IL-1A AND IL-1B BY A COMBINATION OF
MONOCLONAL ANTIBODIES PREVENTS THE DEVELOPMENT AND
REVERSES ESTABLISHED PAIN IN A PRECLINICAL MODEL OF
OSTEOARTHRITIS
R.V. Kamath 1, G. Simler 1, C. Zhou 2, M. Hart 1, S. Joshi 2, T. Ghayur 1,
P. Honore 1. 1Abbott Labs, Worcester, MA; 2Abbott Labs, Abbott Park, IL, USA
Purpose: Osteoarthritis (OA) is a disease of the whole joint with the
signature pathologic feature being articular cartilage loss leading to jointdestruction. The clinical symptoms of OA are pain and functional impair-
ment that includes joint stiffness and dysfunction. Interleukin-1 (IL-1)
plays a major role in the development and progression of osteoarthritis
(OA) both in terms of disease (structure) and symptoms (pain). IL-1a and
IL-1b are two distinct cytokines that bind to the same receptor and are
expressed in synovial membranes, cartilage, and synovial ﬂuid of patients
with OA. The purpose of the studies were to investigate the effects of
blockade of both IL-1a and IL-1b by a combination of anti-IL-1a and anti-
IL-1b monoclonal antibodies (mAbs) on a) the development of pain upon
chronic dosing and b) established pain upon acute dosing in the DMM
model of OA
Methods: Male sv129 mice were anesthetized and then medial menisco-
tibial ligament which anchors the medial meniscus to the tibial plateau
was transected to induce OA. Intraperitoneal (ip) treatments with IL-1
neutralizing antibodies (mouse anti-mouse IL-1amAb, mouse anti-mouse
IL-1b mAb alone, or in combination) was initiated the day of the surgery
and continued twice a week for 28 days (chronic dosing study) or started
on day 27 after surgery and pain evaluated on day 28, 24 hours post-
antibody dosing (acute dosing study). Pain was measured by decrease in
pawwithdrawal threshold of the injured hind limb (mechanical allodynia).
Knees were harvested and histopathologic alterations were scored and
characterized.
Results: Upon chronic dosing in the DMM model of OA, mechanical allo-
dynia (pain) in animals treated with either anti-IL-1a (6 mg/kg) or IL-1b
mAbs (6 mg/kg) was similar to mechanical allodynia observed in the
vehicle control group. However, combination therapy with both antibodies
at 6 mg/kg each signiﬁcantly reduced mechanical allodynia. In this study,
blockade of IL-1a and IL-1b also prevented cartilage degradation while
blocking either IL-1a or IL-1b had no effect. Upon acute dosing, combi-
nation therapy with both antibodies at 6 mg/kg each signiﬁcantly reversed
established mechanical allodynia observed 4 weeks post-surgery.
Conclusions: Our preclinical data demonstrate that combination of mouse
anti-mouse-IL-1a and anti-mouse-IL-1b mAb had signiﬁcant beneﬁcial
effects on histopathological parameters of mouse OA and prevented
development of pain as well as reversed established pain associated with
OA.We have recently reported on a novel dual-speciﬁc biologics approach,
termed Dual-Variable Domain-ImmunoglobulinTM (DVD-IgTM) that can
convert two pre-existing mAbs into a dual targeting agent by combining
the variable domains of two mAbs via naturally occurring linkers. These
preclinical proof of concept studies form the basis for further investigation
of therapeutic IL-1a/b DVD-IgTM molecules in human OA patients.
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ARTICULAR CARTILAGE DEGRADATION INDUCED BY EXTENSIVE
TREADMILL EXERCISE IS GREATLY EXACERBATED BY ESTROGEN
DEPLETION IN MICE.
K. Miyatake, K. Tsuji, J. Yamada, K. Abula, Y. Matsukura, I. Sekiya,
T. Muneta. Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: Osteoarthritis (OA) is considered to be a multifactorial disease
with factors such as chronic inﬂammation, aging, menopause, obesity, and
joint instability. For example, more than 39% of the patients develop OA in
the knee joint after anterior cruciate ligament reconstruction within 8
years. Too much mechanical stress by treadmill exercise induces severe
articular cartilage degradation in rats. Estrogen depletion by ovariectomy
(OVX) accelerates cartilage degradation in mice. These data clearly show
that each factor is involved in the pathogenesis of OA, however, orches-
trated effects of all these factors are still unclear. To analyze the crosstalk
between estrogen signal and mechanotransduction in articular cartilage
homeostasis, we examined articular cartilage damage after treadmill
exercise in OVX mice. Here we report that degree of articular cartilage
degradation induced by extensive treadmill exercise is greatly exacerbated
by estrogen depletion.
Methods: Twenty-four Balb/c mice (8 wks) were randomly divided into 4
groups, OVX+CAGE, OVX+RUN, SHAM+CAGE and SHAM+RUN. Two weeks
after ovariectomy or sham operation, RUN group was subjected to a forced
running for 6 weeks (5 days a week) at 20m/min for 100 minutes by
treadmill while CAGE group were left in cage ad libitum. Integrity of
articular cartilage was assessed by Hematoxylin and Eosin staining and
type II collagen immunostaining of sagittal sections. To assess articular
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stained by Safranin O and 400mm in width of articular cartilage between
anterior and posterior edge of medial meniscus was contoured into 3 areas
according to the dyeability: Grade I; intact cartilage, Grade II; mildly
denatured cartilage with reduced Safranin O staining, and Grade III;
severely denatured cartilage with no Safranin O staining. Each area was
measured using Zeiss Axio Vision Image Analysis system. To analyze the
structural alteration of knee joint after treadmill exercise and OVX, right
knee joints were ﬁxed in 70% ethanol and subjected for mCT analyses.
Animal care and experimental procedures were in accordance with the
guidelines of the ethics committee of our university. Kruskal-Wallis test
followed by Tukey-Kramer methods was used for statistical analysis.
Results: mCT analyses did not reveal the apparent alteration in bone
structure and osteophyte formation between OVX and SHAM group
regardless of treadmill exercise. However we observe signiﬁcant loss in
trabecular bone volume in the OVX group. Image analyses of the articular
cartilage indicated that % area of Grade III was signiﬁcantly higher in
OVX+RUN group (72.1%) if compared to that of SHAM+CAGE (10.6%,
p<0.05). Loss of proteoglycan in articular cartilage was also observed in
both OVX+CAGE and SHAM+RUN groups (Grade III; 24.2% and 20.1%
respectively) although the difference was not statistically signiﬁcant.
Immunohistochemical staining for type II collagen further support these
data, since we observe marked decrease in type II collagen amount in
OVX+RUN group. Hematoxylin and Eosin staining showed that OVX
enhanced cellularity of synovial membrane after forced running suggest-
ing that depletion of estrogenmight enhance syovitis in the damaged joint.
Conclusions: In this study, we showed that the combination of OVX and
forced running greatly accelerated articular cartilage denaturation in mice.
In contrast, the effects of OVX or forced running respectively were not so
apparent on articular cartilage maintenance. These data strongly support
the evidence that OA is a multifactorial disease and our data strongly
indicate the great contribution of hormonal regulation on articular carti-
lage homeostasis in adults. Crosstalk between hormonal regulation and
mechanotransduction on articular cartilage homeostasis is still unclear,
our data suggest that estrogen depletion enhances inﬂammatory response
after articular cartilage damage. Since prevalence of OA greatly increased
after menopause, our experimental system will be of great use for
analyzing OA progression in aged women.
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INCREASED SENSITIVITY TO NERVE GROWTH FACTOR IN THE
MONOSODIUM-IODOACETATE MODEL OF OSTEOARTHRITIS
S. Ashraf, P.I. Mapp, J. Burston, P. Millns, V. Chapman, D.A. Walsh. Univ. of
Nottingham, Nottingham, United Kingdom
Purpose: Osteoarthritis (OA) is often characterised by episodes of
increased pain with associated synovitis. Nerve growth factor (NGF) levels
are increased in the OA joint, and during inﬂammation. Pain ﬂares may be
due to either increased release, or to increased sensitivity to NGF. It was
hypothesised that OA leads to a sustained and enhanced increase in NGF-
induced pain behaviour. The Aim of this study was to ﬁnd out whether
pain behaviour induced by intra-articular injection of NGF is increased in
the MIA model of OA and to explore possible mechanisms behind this
enhanced response to NGF.
Methods: OA was induced in the left knee joint on day 0 in male Sprague
Dawley rats (n¼8 animals/group) weighing approximately 200g, by intra-
articular injection of 1mg of MIA in 50ml saline. Saline injected animals
were used as non-arthritic controls. Intra-articular injection of NGF (10mg/
50ml) or saline control was given in the left knee joint when OA pathology
had fully established (day 20). In order to explore whether inﬂammation
during the development of OA may contribute to any increased sensitivity
to NGF, indomethacin (2mg/kg, daily, orally) or saline control was given
from before induction of OA (day -1) to day 18. To avoid confounding by
analgesic actions of indomethacin, animals underwent a 2 day washout
period before NGF injection. Joint tissues were harvested from parallel
groups of animals at day 20, corresponding to the time of NGF injection in
order to explore mediation of indomethacin effect through altered joint
structure. Synovial inﬂammation was measured as the macrophage frac-
tional area (% synovium occupied by ED1+ve cells), thickness of the
synovial lining and joint swelling. Chondropathy, channels breaching theosteochondral junction (OCJ) and osteophytes were scored as measures of
structural damage. Pain behaviour was measured as hind-limb weight-
bearing asymmetry. Data are reported as the mean [95% conﬁdence
interval].
Results: Pain behaviour was increased following induction of OA. Pain
behaviour was reduced during the period of indomethacin treatment in OA
animals to saline injected control levels by day 18 whereas vehicle-treated
arthritic controls still showed an increase in pain behaviour. Enhanced and
sustained pain-response was observed following intra-articular injection
of NGF in OA animals (31.4 [24.6-38.2] g compared with that observed in
non-arthritic controls (7.1 [4.3-9.8] g, p<0.001). Pre-treatment with
indomethacin signiﬁcantly inhibited the subsequent pain behavioural
response to intra-articular NGF injection in OA knees (17.3 [12.1-22.5] g)
compared to vehicle treated arthritic controls (31.4 [24.6-38.2] g,
p<0.001). Synovial inﬂammation, chondropathy, channels breaching the
OCJ and osteophyte scores at day 20 (before NGF injection) were not
affected by indomethacin treatment.
Conclusions: NGF-induced pain behaviour is increased and sustained in
the MIA model of OA. Pre-treatment with indomethacin reduced this
enhanced response. This effect of indomethacin was not associated with
any reduction in joint damage nor any signiﬁcant sustained reduction in
inﬂammation. Although synovitis may contribute to the development of
this enhanced sensitivity to NGF, involvement of other factors such as
possible effects of indomethacin on pain processing at the level of the
spinal cord, deserve further investigation.
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INHIBITION OF TRANSFORMING GROWTH FACTOR ALPHA SIGNALING
SLOWS PROGRESSION OF OSTEOARTHRITIS IN A DMM MODEL
S.E. Usmani, T.C. Appleton, M.A. Pest, V. Ulici, I.D. Welch, T.L. Hill,
F. Beier. The Univ. of Western Ontario, London, ON, Canada
Purpose: No cures currently exist for the degenerative joint disease
osteoarthritis (OA). Furthermore, the complex andmulti-variable nature of
OA continues to challenge the development of effective therapies. In an
attempt to identify potential targets for disease modifying osteoarthritis
drugs (DMOADs), our lab recently established a surgical model of OA to
study gene expression changes in degenerating cartilage. Transforming
growth factor alpha (TGFa) gene expression was upregulated in our model
and further in vitro studies showed that TGFa suppressed chondrocyte
expression of anabolic factors aggrecan and type II collagen and increased
expression of the catabolic factor matrix metalloproteinase 13 (MMP13).
We thus identiﬁed TGFa as a novel therapeutic OA target. The purpose of
this project is to examine the role of TGFa in the development of OA in vivo.
We hypothesize that inhibition of TGFa signaling will delay disease
progression in surgical OA models.
Methods: Ten week old male Tgfa null mice and control littermates
received either destabilization of medial meniscus (DMM) or sham
surgery. At 7 and 14 weeks post-surgery knee joint histopathology was
assessed using the OARSI scoring method and tissues were immuno-
stained for disease markers such as MMP13 and type II collagen neo-
epitopes. In addition, we performed DMM and sham surgeries on six
month old mice to create a more severe surgical model and assessed OA
histopathology after 7 weeks. Lastly, we observed the development of
spontaneous OA in eighteenmonth old Tgfa and control mice in a variety of
joints.
Results: DMM surgery produced mild and moderate OA in ten week old
mice after 7 and 14 weeks. Tgfa null mice had lower OARSI scores and
expressed less MMP13 and type II collagen neoepitopes than their control
littermates. When DMM was performed on six month old animals, severe
OA was observed. In older mice however, there was no protection in the
Tgfa KO group compared to controls. Eighteen month old mice developed
mild spontaneous OA, but again there was no protection in the Tgfa KO
group when compared to controls.
Conclusions: TGFa signaling plays an important role in osteoarthritis
progression in vivo in mild surgical models. However, in severe OA models
and in spontaneous OA development, lack of TGFa alone does not appear to
be sufﬁcient to prevent or delay disease progression. TGFa should be
investigated further as a potential target for DMOAD development, espe-
cially in the acute post-injury stages.
